Updating experimental models of diabetic cardiomyopathy

Journal of Diabetes Research

Volumn 2015, Issue , 2015, Pages

  Fuentes Antras, J ^a   Picatoste, B ^a,b   Gomez Hernandez, A ^b,c   Egido, J ^a,b   Tunon, J ^a   Lorenzo, O ^a,b  

^a UAM)   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; GLUCOSE TRANSPORTER 4; STREPTOZOCIN;

APOPTOSIS; CALCIUM MOBILIZATION; DIABETIC CARDIOMYOPATHY; DIABETIC PATIENT; DIASTOLIC DYSFUNCTION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA MODIFICATION; ENDOPLASMIC RETICULUM STRESS; EXTRACELLULAR MATRIX; FIBROSING ALVEOLITIS; HEART FAILURE; HEART FUNCTION; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART MUSCLE INJURY; HEART MUSCLE METABOLISM; HEART PERFORMANCE; HEART VENTRICLE HYPERTROPHY; HISTOPATHOLOGY; HUMAN; INFLAMMATION; INSULIN RESISTANCE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; RISK FACTOR; STEATOSIS; ANIMAL; CARDIAC MUSCLE; DISEASE MODEL; HEART; METABOLISM; PATHOPHYSIOLOGY;

ANIMALS; DIABETES MELLITUS, TYPE 2; DIABETIC CARDIOMYOPATHIES; DISEASE MODELS, ANIMAL; HEART; MYOCARDIUM;

EID: 84929359364     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2015/656795     Document Type: Review

References (153)

1. M. Niemann, S. Herrmann, G. Ertl, and F. Weidemann, "Echocardiography in diabetic cardiomyopathy, " Herz, vol. 38, no. 1, pp. 42-47, 2013.
2. J. N. Khan, E. G. Wilmot, M. Leggate et al., "Subclinical diastolic dysfunction in young adults with Type 2 diabetes mellitus: a multiparametric contrast-enhanced cardiovascular magnetic resonance pilot study assessing potential mechanisms, " European Heart Journal-Cardiovascular Imaging, vol. 15, no. 11, pp. 1263-1269, 2014.
3. C. Jellis, J. Wright, D. Kennedy et al., "Association of imaging markers of myocardial fibrosis with metabolic and functional disturbances in early diabetic cardiomyopathy, " Circulation: Cardiovascular Imaging, vol. 4, no. 6, pp. 693-702, 2011.
4. S. Gao, D. Ho, D. E. Vatner, and S. F. Vatner, "Echocardiography in mice, " Current Protocols in Mouse Biology, vol. 1, pp. 71-83, 2011.
5. C. Christoffersen, E. Bollano, M. L. S. Lindegaard et al., "Cardiac lipid accumulation associated with diastolic dysfunction in obese mice, " Endocrinology, vol. 144, no. 8, pp. 3483-3490, 2003.
6. L. M. Semeniuk, A. J. Kryski, and D. L. Severson, "Echocardiographic assessment of cardiac function in diabetic db/db and transgenic db/db-hGLUT4 mice, " American Journal of Physiology-Heart and Circulatory Physiology, vol. 283, no. 3, pp. H976-H982, 2002.
7. A. van den Bergh, W. Flameng, and P. Herijgers, "Type II diabetic mice exhibit contractile dysfunction but maintain cardiac output by favourable loading conditions, " European Journal of Heart Failure, vol. 8, no. 8, pp. 777-783, 2006.
8. Y.-T. Zhou, P. Grayburn, A. Karimet al., "Lipotoxic heart disease in obese rats: implications for human obesity, " Proceedings of the NationalAcademy of Sciences of theUnited States ofAmerica, vol. 97, no. 4, pp. 1784-1789, 2000.
9. A. Daniels, D. Linz, M. van Bilsen et al., "Long-term severe diabetes only leads to mild cardiac diastolic dysfunction in Zucker diabetic fatty rats, " European Journal of Heart Failure, vol. 14, no. 2, pp. 193-201, 2012.
10. E. Ramrez, M. Klett-Mingo, S. Ares-Carrasco et al., "Eplerenone attenuated cardiac steatosis, apoptosis and diastolic dysfunction in experimental type-II diabetes, " Cardiovascular Diabetology, vol. 12, no. 1, article 172, 2013.
11. K. Mizushige, L. Yao, T. Noma et al., "Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model, " Circulation, vol. 101, no. 8, pp. 899-907, 2000.
12. B. Picatoste, E. Ramrez, A. Caro-Vadillo et al., "Sitagliptin reduces cardiac apoptosis, hypertrophy and fibrosis primarily by insulin-Dependent mechanisms in experimental type-II diabetes. Potential roles of GLP-1 isoforms, " PLoS ONE, vol. 8, no. 10, Article ID e78330, 2013.
13. C. X. Fang, F. Dong, D. P. Thomas, H. Ma, L. He, and J. Ren, "Hypertrophic cardiomyopathy in high-fat diet-induced obesity: role of suppression of forkhead transcription factor and atrophy gene transcription, " The American Journal of Physiology-Heart and Circulatory Physiology, vol. 295, no. 3, pp. H1206-H1215, 2008.
14. Z. Vasanji, E. J. F. Cantor, D. Juric, M. Moyen, and T. Netticadan, "Alterations in cardiac contractile performance and sarcoplasmic reticulum function in sucrose-fed rats is associated with insulin resistance, " The American Journal of Physiology-Cell Physiology, vol. 291, no. 4, pp. C772-C780, 2006.
15. T. Pulinilkunnil, P. C. Kienesberger, J. Nagendran, N. Sharma, M. E. Young, and J. R. B. Dyck, "Cardiac-specific adipose triglyceride lipase overexpression protects from cardiac steatosis and dilated cardiomyopathy following diet-induced obesity, " International Journal of Obesity, vol. 38, no. 2, pp. 205-215, 2014.
16. J. B. Somaratne, G. A. Whalley, K. K. Poppe et al., "Screening for left ventricular hypertrophy in patients with type 2 diabetes mellitus in the community, " Cardiovascular Diabetology, vol. 10, article 29, 2011.
17. A. Dei Cas, V. Spigoni, V. Ridolfi, and M. Metra, "Diabetes and chronic heart failure: from diabetic cardiomyopathy to therapeutic approach, " Endocrine, Metabolic and Immune Disorders-Drug Targets, vol. 13, no. 1, pp. 38-50, 2013.
18. S. Zibadi, F. Cordova, E. H. Slack, R. R. Watson, andD. F. Larson, "Leptin's regulation of obesity-induced cardiac extracellular matrix remodeling, " Cardiovascular Toxicology, vol. 11, no. 4, pp. 325-333, 2011.
19. E. J. Cox and S. A. Marsh, "A systematic review of fetal genes as biomarkers of cardiac hypertrophy in rodent models of diabetes, " PLoS ONE, vol. 9, no. 3, Article ID e92903, 2014.
20. O. Nemoto, M. Kawaguchi, H. Yaoita, K. Miyake, K. Maehara, and Y. Maruyama, "Left ventricular dysfunction and remodeling in streptozotocin-induced diabetic rats, " Circulation Journal, vol. 70, no. 3, pp. 327-334, 2006.
21. S. Ares-Carrasco, B. Picatoste, A. Benito-Martn et al., "Myocardial fibrosis and apoptosis, but not inflammation, are present in long-term experimental diabetes, " The American Journal of Physiology-Heart andCirculatory Physiology, vol. 297, no. 6, pp. H2109-H2119, 2009.
22. Y. Li, J. Ma, H. Zhu et al., "Targeted inhibition of calpain reduces myocardial hypertrophy and fibrosis in mouse models of type 1 diabetes, " Diabetes, vol. 60, no. 11, pp. 2985-2994, 2011.
23. Y. Wang, W. Sun, B. Du et al., "Therapeutic effect of MG-132 on diabetic cardiomyopathy is associated with its suppression of proteasomal activities: roles of Nrf2 and NF-B, " American Journal of Physiology-Heart and Circulatory Physiology, vol. 304, no. 4, pp. H567-H578, 2013.
24. R. Basu, G. Y. Oudit, X. Wang et al., "Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function, " The American Journal of Physiology-Heart and Circulatory Physiology, vol. 297, no. 6, pp. H2096-H2108, 2009.
25. A. Van Den Bergh, A. Vanderper, P. Vangheluwe et al., "Dyslipidaemia in type II diabetic mice does not aggravate contractile impairment but increases ventricular stiffness, " Cardiovascular Research, vol. 77, no. 2, pp. 371-379, 2008.
26. P. Yue, T. Arai, M. Terashima et al., "Magnetic resonance imaging of progressive cardiomyopathic changes in the db/db mouse, " American Journal of Physiology: Heart and Circulatory Physiology, vol. 292, no. 5, pp. H2106-H2118, 2007.
27. L. Pereira, J. Matthes, I. Schuster et al., "Mechanisms of [Ca2+] transient decrease in cardiomyopathy of db/db type 2 diabetic mice, " Diabetes, vol. 55, no. 3, pp. 608-615, 2006.
28. S. Fredersdorf, C. Thumann, C. Ulucan et al., "Myocardial hypertrophy and enhanced left ventricular contractility in Zucker diabetic fatty rats, " Cardiovascular Pathology, vol. 13, no. 1, pp. 11-19, 2004.
29. M. Conti, I. M. Renaud, B. Poirier et al., "High levels ofmyocardial antioxidant defense in aging nondiabetic normotensive Zucker obese rats, " The American Journal of Physiology-Regulatory Integrative and Comparative Physiology, vol. 286, no. 4, pp. R793-R800, 2004.
30. M. Desrois, R. J. Sidell, D. Gauguier, C. L. Davey, G. K. Radda, and K. Clarke, "Gender differences in hypertrophy, insulin resistance and ischemic injury in the aging type 2 diabetic rat heart, " Journal of Molecular and Cellular Cardiology, vol. 37, no. 2, pp. 547-555, 2004.
31. S. Devanathan, S. T. Nemanich, A. Kovacs, N. Fettig, R. J. Gropler, and K. I. Shoghi, "Genomic and metabolic disposition of non-obese type 2 diabetic rats to increased myocardial Fatty Acid metabolism, " PLoS ONE, vol. 8, no. 10, Article ID e78477, 2013.
32. S. Nunes, E. Soares, J. Fernandes et al., "Early cardiac changes in a rat model of prediabetes: brain natriuretic peptide overexpression seems to be the best marker, " Cardiovascular Diabetology, vol. 12, article 44, 2013.
33. L. N. Axelsen, J. B. Lademann, J. S. Petersen et al., "Cardiac and metabolic changes in long-term high fructose-fat fed rats with severe obesity and extensive intramyocardial lipid accumulation, " TheAmerican Journal of Physiology-Regulatory Integrative and Comparative Physiology, vol. 298, no. 6, pp. R1560-R1570, 2010.
34. A. K. M. Tarikuz Zaman, D. L. McLean, and B. E. Sobel, "The efficacy and tolerability of azilsartan in obese insulinresistantmice with left ventricular pressure overload, " Journal of Cardiovascular Pharmacology, vol. 62, no. 4, pp. 381-387, 2013.
35. M. H. Noyan-Ashraf, E. A. Shikatani, I. Schuiki et al., "A glucagon-like peptide-1 analog reverses the molecular pathology and cardiac dysfunction of a mouse model of obesity, " Circulation, vol. 127, no. 1, pp. 74-85, 2013.
36. J. D. Schilling and D. L. Mann, "Diabetic cardiomyopathy: bench to bedside, " Heart Failure Clinics, vol. 8, no. 4, pp. 619-631, 2012.
37. D. L. Mann, "Inflammatory mediators and the failing heart: past, present, and the foreseeable future, " Circulation Research, vol. 91, no. 11, pp. 988-998, 2002.
38. W. Huang andC. K. Glass, "Nuclear receptors and inflammation control: molecular mechanisms and pathophysiological relevance, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 8, pp. 1542-1549, 2010.
39. J. Fuentes-Antrás, A. M. Ioan, J. Tunón, J. Egido, and O. Lorenzo, "Activation of toll-like receptors and inflammasome complexes in the diabetic cardiomyopathy-associated inflammation, " International Journal of Endocrinology, vol. 2014, Article ID 847827, 10 pages, 2014.
40. V. Chavali, S. C. Tyagi, and P. K. Mishra, "Differential expression of dicer, miRNAs, and inflammatory markers in diabetic Ins2+/-akita hearts, " Cell Biochemistry and Biophysics, vol. 68, no. 1, pp. 25-35, 2014.
41. J. Mori, V. B. Patel, O. Abo Alrob et al., "Angiotensin 1-7 ameliorates diabetic cardiomyopathy and diastolic dysfunction in db/db mice by reducing lipotoxicity and inflammation, " Circulation. Heart Failure, vol. 7, no. 2, pp. 327-339, 2014.
42. A. Jadhav, S. Tiwari, P. Lee, and J. F. Ndisang, "The heme oxygenase system selectively enhances the anti-inflammatory macrophage-m2 phenotype, reduces pericardial adiposity, and ameliorated cardiac injury in diabetic cardiomyopathy in zucker diabetic fatty rats, " Journal of Pharmacology and Experimental Therapeutics, vol. 345, no. 2, pp. 239-249, 2013.
43. H.-T. Wang, C.-F. Liu, T.-H. Tsai et al., "Effect of obesity reduction on preservation of heart function and attenuation of left ventricular remodeling, oxidative stress and inflammation in obese mice, " Journal of Translational Medicine, vol. 10, no. 1, article 145, 2012.
44. D. Alvarez-Guardia, X. Palomer, T. Coll et al., "PPAR/activation blocks lipid-induced inflammatory pathways in mouse heart and human cardiac cells, " Biochimica et Biophysica Acta, vol. 1811, no. 2, pp. 59-67, 2011.
45. K. J. Way, K. Isshiki, K. Suzuma et al., "Expression of connective tissue growth factor is increased in injuredmyocardiumassociated with protein kinase C 2 activation and diabetes, " Diabetes, vol. 51, no. 9, pp. 2709-2718, 2002.
46. S. Katayama, M. Abe, K. Negishi, K. Takahashi, J. Ishii, and K. Komeda, "Reciprocal changes in left ventricular collagen 1 chain gene expression between types I and IV in spontaneously diabetic rats, " Diabetes Research and Clinical Practice, vol. 26, no. 3, pp. 163-169, 1994.
47. J. E. Lee, C.-O. Yi, B. T. Jeon et al., "-lipoic acid attenuates cardiac fibrosis in Otsuka Long-Evans Tokushima Fatty rats, " Cardiovascular Diabetology, vol. 11, article 111, 2012.
48. G. F. Lewis, A. Carpentier, K. Adeli, and A. Giacca, "Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes, " Endocrine Reviews, vol. 23, no. 2, pp. 201-229, 2002.
49. G. Korosoglou, P. M. Humpert, J. Ahrens et al., "Left ventricular diastolic function in type 2 diabetes mellitus is associated with myocardial triglyceride content but not with impaired myocardial perfusion reserve, " Journal of Magnetic Resonance Imaging, vol. 35, no. 4, pp. 804-811, 2012.
50. M. Ueno, J. Suzuki, Y. Zenimaru et al., "Cardiac overexpression of hormone-sensitive lipase inhibits myocardial steatosis and fibrosis in streptozotocin diabetic mice, " The American Journal of Physiology-Endocrinology and Metabolism, vol. 294, no. 6, pp. E1109-E1118, 2008.
51. B. Dong, D. Qi, L. Yang et al., "TLR4 regulates cardiac lipid accumulation and diabetic heart disease in the nonobese diabetic mouse model of type 1 diabetes, " The American Journal of Physiology-Heart and Circulatory Physiology, vol. 303, no. 6, pp. H732-H742, 2012.
52. L. A. Barouch, D. Gao, L. Chen et al., "Cardiac myocyte apoptosis is associated with increased DNA damage and decreased survival inmurine models of obesity, " Circulation Research, vol. 98, no. 1, pp. 119-124, 2006.
53. Y. S. Diniz, P. P. Santos, H. B. Assalin et al., "Conjugated linoleic acid and cardiac health: oxidative stress and energetic metabolism in standard and sucrose-rich diets, " European Journal of Pharmacology, vol. 579, no. 1-3, pp. 318-325, 2008.
54. A. Frustaci, J. Kajstura, C. Chimenti et al., "Myocardial cell death in human diabetes, " Circulation Research, vol. 87, no. 12, pp. 1123-1132, 2000.
55. S. A. Andrabi, T. M. Dawson, andV. L. Dawson, "Mitochondrial and nuclear cross talk in cell death: parthanatos, " Annals of the New York Academy of Sciences, vol. 1147, pp. 233-241, 2008.
56. P. Puthanveetil, D. Zhang, Y. Wang et al., "Diabetes triggers a PARP1 mediated death pathway in the heart through participation of FoxO1, " Journal of Molecular and Cellular Cardiology, vol. 53, no. 5, pp. 677-686, 2012.
57. F. Fiordaliso, B. Li, R. Latini et al., "Myocyte death in streptozotocin-induced diabetes in rats is angiotensin IIdependent, " Laboratory Investigation, vol. 80, no. 4, pp. 513-527, 2000.
58. Z. Xie, K. Lau, B. Eby et al., "Improvement of cardiac functions by chronic metformin treatment is associated with enhanced cardiac autophagy in diabetic OVE26 mice, " Diabetes, vol. 60, no. 6, pp. 1770-1778, 2011.
59. E. Shen, Y. Li, L. Shan et al., "Rac1 is required for cardiomyocyte apoptosis during hyperglycemia, " Diabetes, vol. 58, no. 10, pp. 2386-2395, 2009.
60. R. S. Guleria, R. Choudhary, T. Tanaka, K. M. Baker, and J. Pan, "Retinoic acid receptor-mediated signaling protects cardiomyocytes from hyperglycemia induced apoptosis: role of the renin-angiotensin system, " Journal of Cellular Physiology, vol. 226, no. 5, pp. 1292-1307, 2011.
61. H. Matsui, T. Yokoyama, K. Sekiguchi et al., "Stearoyl-CoA desaturase-1 (SCD1) augments saturated fatty acid-induced lipid accumulation and inhibits apoptosis in cardiac myocytes, " PLoS ONE, vol. 7, no. 3, Article ID e33283, 2012.
62. X. Shen, S. Zheng, V. Thongboonkerd et al., "Cardiac mitochondrial damage and biogenesis in a chronic model of type 1 diabetes, " American Journal of Physiology-Endocrinology and Metabolism, vol. 287, no. 5, pp. E896-E905, 2004.
63. E. Aasum, A. D. Hafstad, D. L. Severson, and T. S. Larsen, "Agedependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db mice, " Diabetes, vol. 52, no. 2, pp. 434-441, 2003.
64. P. K. Mazumder, B. T. O'Neill, M. W. Roberts et al., "Impaired cardiac efficiency and increased fatty acid oxidation in insulinresistant ob/ob mouse hearts, " Diabetes, vol. 53, no. 9, pp. 2366-2374, 2004.
65. K. Ballal, C. R. Wilson, R. Harmancey, and H. Taegtmeyer, "Obesogenic high fat western diet induces oxidative stress and apoptosis in rat heart, "Molecular and Cellular Biochemistry, vol. 344, no. 1-2, pp. 221-230, 2010.
66. S. Nunes, E. Soares, J. Fernandes et al., "Early cardiac changes in a rat model of prediabetes: brain natriuretic peptide overexpression seems to be the best marker, " Cardiovascular Diabetology, vol. 12, no. 1, article 44, 2013.
67. Z. Y. Fang, J. B. Prins, and T. H. Marwick, "Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications, " Endocrine Reviews, vol. 25, no. 4, pp. 543-567, 2004.
68. H. Bugger and E. D. Abel, "Mitochondria in the diabetic heart, " Cardiovascular Research, vol. 88, no. 2, pp. 229-240, 2010.
69. T.-I. Lee, Y.-H. Kao, Y.-C. Chen, J.-H. Huang, F.-C. Hsiao, and Y.-J. Chen, "Peroxisome proliferator-activated receptors modulate cardiac dysfunction in diabetic cardiomyopathy, " Diabetes Research and Clinical Practice, vol. 100, no. 3, pp. 330-339, 2013.
70. C. E. Flarsheim, I. L. Grupp, and M. A. Matlib, "Mitochondrial dysfunction accompanies diastolic dysfunction in diabetic rat heart, "The American Journal of Physiology-Heart and Circulatory Physiology, vol. 271, no. 1, part 2, pp. H192-H202, 1996.
71. H. Bugger, S. Boudina, X. X. Hu et al., "Type 1 diabetic akita mouse hearts are insulin sensitive but manifest structurally abnormal mitochondria that remain coupled despite increased uncoupling protein 3, " Diabetes, vol. 57, no. 11, pp. 2924-2932, 2008.
72. L. S. Golfman, C. R. Wilson, S. Sharma et al., "Activation of PPAR enhances myocardial glucose oxidation and improves contractile function in isolated working hearts of ZDF rats, " American Journal of Physiology-Endocrinology and Metabolism, vol. 289, no. 2, pp. E328-E336, 2005.
73. M. A. Cole, A. J. Murray, L. E. Cochlin et al., "A high fat diet increases mitochondrial fatty acid oxidation and uncoupling to decrease efficiency in rat heart, " Basic Research in Cardiology, vol. 106, no. 3, pp. 447-457, 2011.
74. J. R. Ussher, T. R. Koves, J. S. Jaswal et al., "Insulin-stimulated cardiac glucose oxidation is increased in high-fat diet-induced obese mice lacking malonyl CoA decarboxylase, " Diabetes, vol. 58, pp. 1766-1775, 2009.
75. O. Ilkun and S. Boudina, "Cardiac dysfunction and oxidative stress in the metabolic syndrome: an update on antioxidant therapies, " Current Pharmaceutical Design, vol. 19, no. 27, pp. 4806-4817, 2013.
76. S. Ghosh, T. Pulinilkunnil, G. Yuen et al., "Cardiomyocyte apoptosis induced by short-term diabetes requires mitochondrial GSH depletion, " American Journal of Physiology-Heart and Circulatory Physiology, vol. 289, no. 2, pp. H768-H776, 2005.
77. M. Hamblin, D. B. Friedman, S. Hill, R. M. Caprioli, H. M. Smith, and M. F. Hill, "Alterations in the diabetic myocardial proteome coupled with increased myocardial oxidative stress underlies diabetic cardiomyopathy, " Journal of Molecular and Cellular Cardiology, vol. 42, no. 4, pp. 884-895, 2007.
78. Y. Song, Y. Du, S. D. Prabhu, and P. N. Epstein, "Diabetic cardiomyopathy in OVE26 mice shows mitochondrial ROS production and divergence between in vivo and in vitro contractility, " Review of Diabetic Studies, vol. 4, no. 3, pp. 159-168, 2007.
79. Q. Liang, E. C. Carlson, R. V. Donthi, P. M. Kralik, X. Shen, and P. N. Epstein, "Overexpression of metallothionein reduces diabetic cardiomyopathy, " Diabetes, vol. 51, no. 1, pp. 174-181, 2002.
80. S. Boudina, S. Sena, H. Theobald et al., "Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins, " Diabetes, vol. 56, no. 10, pp. 2457-2466, 2007.
81. S. Boudina, S. Sena, B. T. O'Neill, P. Tathireddy, M. E. Young, and E. D. Abel, "Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity, " Circulation, vol. 112, no. 17, pp. 2686-2695, 2005.
82. S. Boudina and E. D. Abel, "Diabetic cardiomyopathy revisited, " Circulation, vol. 115, no. 25, pp. 3213-3223, 2007.
83. J. P. Vázquez-Medina, I. Popovich, M. A. Thorwald et al., "Angiotensin receptor-mediated oxidative stress is associated with impaired cardiac redox signaling and mitochondrial function in insulin-resistant rats, " American Journal of Physiology-Heart and Circulatory Physiology, vol. 305, no. 4, pp. H599-H607, 2013.
84. D. L. Santos, C. M. Palmeira, R. Seicą et al., "Diabetes andmitochondrial oxidative stress: a study using heart mitochondria from the diabetic Goto-Kakizaki rat, " Molecular and Cellular Biochemistry, vol. 246, no. 1-2, pp. 163-170, 2003.
85. J. Grijalva, S. Hicks, X. Zhao et al., "Exercise training enhanced myocardial endothelial nitric oxide synthase (eNOS) function in diabetic Goto-Kakizaki (GK) rats, " Cardiovascular Diabetology, vol. 7, article 34, 2008.
86. H. K. Vincent, S. K. Powers, A. J. Dirks, and P. J. Scarpace, "Mechanism for obesity-induced increase in myocardial lipid peroxidation, " International Journal of Obesity, vol. 25, no. 3, pp. 378-388, 2001.
87. P. Wang, S. G. Lloyd, H. Zeng, A. Bonen, and J. C. Chatham, "Impact of altered substrate utilization on cardiac function in isolated hearts from Zucker diabetic fatty rats, " American Journal of Physiology-Heart and Circulatory Physiology, vol. 288, no. 5, pp. H2102-H2110, 2005.
88. B. Turan and G. Vassort, "Ryanodine receptor: a new therapeutic target to control diabetic cardiomyopathy, " Antioxidants and Redox Signaling, vol. 15, no. 7, pp. 1847-1861, 2011.
89. C. E. Flarsheim, I. L. Grupp, and M. A. Matlib, "Mitochondrial dysfunction accompanies diastolic dysfunction in diabetic rat heart, "The American Journal of Physiology-Heart and Circulatory Physiology, vol. 271, no. 1, pp. H192-H202, 1996.
90. P. M. Kralik, G. Ye, N. S. Metreveli, X. Shen, and P. N. Epstein, "Cardiomyocyte dysfunction in models of type 1 and type 2 diabetes, " Cardiovascular Toxicology, vol. 5, no. 3, pp. 285-292, 2005.
91. J. Ren and A. M. Bode, "Altered cardiac excitation-contraction coupling in ventricular myocytes from spontaneously diabetic BB rats, " American Journal of Physiology: Heart and Circulatory Physiology, vol. 279, no. 1, pp. H238-H244, 2000.
92. S.-Y. Li, X. Yang, A. F. Ceylan-Isik, M. Du, N. Sreejayan, and J. Ren, "Cardiac contractile dysfunction in Lep/Lep obesity is accompanied by NADPH oxidase activation, oxidative modification of sarco(endo)plasmic reticulum Ca2+-ATPase and myosin heavy chain isozyme switch, " Diabetologia, vol. 49, no. 6, pp. 1434-1446, 2006.
93. D. D. Belke, E. A. Swanson, and W. H. Dillmann, "Decreased sarcoplasmic reticulum activity and contractility in diabetic db/db mouse heart, " Diabetes, vol. 53, no. 12, pp. 3201-3208, 2004.
94. K. A. Salem, T. E. Adrian, M. A. Qureshi, K. Parekh, M. Oz, and F. C. Howarth, "Shortening and intracellular Ca2+ in ventricular myocytes and expression of genes encoding cardiac muscle proteins in early onset type 2 diabetic Goto-Kakizaki rats, " Experimental Physiology, vol. 97, no. 12, pp. 1281-1291, 2012.
95. K. M. Mellor, I. R. Wendt, R. H. Ritchie, and L. M. D. Delbridge, "Fructose diet treatment in mice induces fundamental disturbance of cardiomyocyte Ca2+ handling and myofilament responsiveness, " The American Journal of Physiology-Heart and Circulatory Physiology, vol. 302, no. 4, pp. H964-H972, 2012.
96. H. Wakasaki, D. Koya, F. J. Schoen et al., "Targeted overexpression of protein kinase C 2 isoform in myocardium causes cardiomyopathy, " Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 17, pp. 9320-9325, 1997.
97. E. D. Abel, H. C. Kaulbach, R. Tian et al., "Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 fromthe heart, "The Journal of Clinical Investigation, vol. 104, no. 12, pp. 1703-1714, 1999.
98. A. A. Domenighetti, V. R. Danes, C. L. Curl, J. M. Favaloro, J. Proietto, and L. M. D. Delbridge, "Targeted GLUT-4 deficiency in the heart induces cardiomyocyte hypertrophy and impaired contractility linked with Ca2+ and proton flux dysregulation, " Journal of Molecular and Cellular Cardiology, vol. 48, no. 4, pp. 663-672, 2010.
99. Y. Li, A. R. Wende, O. Nunthakungwan et al., "Cytosolic, but not mitochondrial, oxidative stress is a likely contributor to cardiac hypertrophy resulting from cardiac specific GLUT4 deletion in mice, " FEBS Journal, vol. 279, no. 4, pp. 599-611, 2012.
100. A. Mora, A. M. Davies, L. Bertrand et al., "Deficiency of PDK1 in cardiac muscle results in heart failure and increased sensitivity to hypoxia, " The EMBO Journal, vol. 22, no. 18, pp. 4666-4676, 2003.
101. R. H. Ritchie, J. E. Love, K. Huynh et al., "Enhanced phosphoinositide 3-kinase(p110) activity prevents diabetes-induced cardiomyopathy and superoxide generation in a mouse model of diabetes, " Diabetologia, vol. 55, no. 12, pp. 3369-3381, 2012.
102. H. Li, X. Wang, Y. Mao et al., "Long term liver specific glucokinase gene defect induced diabetic cardiomyopathy by up regulating NADPH oxidase and down regulating insulin receptor and p-AMPK, " Cardiovascular Diabetology, vol. 13, no. 1, article 24, 2014.
103. D. D. Belke, S. Betuing, M. J. Tuttle et al., "Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression, " Journal of Clinical Investigation, vol. 109, no. 5, pp. 629-639, 2002.
104. S. Boudina, H. Bugger, S. Sena et al., "Contribution of impaired myocardial insulin signaling to mitochondrial dysfunction and oxidative stress in the heart, " Circulation, vol. 119, no. 9, pp. 1272-1283, 2009.
105. B. N. Finck, X. Han, M. Courtois et al., "A critical role for PPAR-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content, " Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 3, pp. 1226-1231, 2003.
106. B. N. Finck, J. J. Lehman, T. C. Leone et al., "The cardiac phenotype induced by PPAR overexpression mimics that caused by diabetes mellitus, " Journal of Clinical Investigation, vol. 109, no. 1, pp. 121-130, 2002.
107. N.-H. Son, T.-S. Park, H. Yamashita et al., "Cardiomyocyte expression of PPAR leads to cardiac dysfunction in mice, " Journal of Clinical Investigation, vol. 117, no. 10, pp. 2791-2801, 2007.
108. N.-H. Son, S. Yu, J. Tuinei et al., "PPAR-induced cardiolipotoxicity in mice is ameliorated by PPAR deficiency despite increases in fatty acid oxidation, " Journal of Clinical Investigation, vol. 120, no. 10, pp. 3443-3454, 2010.
109. H.-C. Chiu, A. Kovacs, D. A. Ford et al., "A novelmouse model of lipotoxic cardiomyopathy, " Journal of Clinical Investigation, vol. 107, no. 7, pp. 813-822, 2001.
110. L. Liu, X. J. Shi, K. G. Bharadwaj et al., "DGAT1 expression increases heart triglyceride content but ameliorates lipotoxicity, " The Journal of Biological Chemistry, vol. 284, no. 52, pp. 36312-36323, 2009.
111. H. Yagyu, G. Chen, M. Yokoyama et al., "Lipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy, " Journal of Clinical Investigation, vol. 111, no. 3, pp. 419-426, 2003.
112. M. Yokoyama, H. Yagyu, Y. Hu et al., "Apolipoprotein B production reduces lipotoxic cardiomyopathy. Studies in heartspecific lipoprotein lipase transgenic mouse, " The Journal of Biological Chemistry, vol. 279, no. 6, pp. 4204-4211, 2004.
113. H.-C. Chiu, A. Kovacs, R. M. Blanton et al., "Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy, " Circulation Research, vol. 96, no. 2, pp. 225-233, 2005.
114. T. P. Flagg, O. Cazorla, M. S. Remedi et al., "Ca2+-independent alterations in diastolic sarcomere length and relaxation kinetics in a mouse model of lipotoxic diabetic cardiomyopathy, " Circulation Research, vol. 104, no. 1, pp. 95-103, 2009.
115. G. Haemmerle, A. Lass, R. Zimmermann et al., "Defective lipolysis and altered energymetabolism in mice lacking adipose triglyceride lipase, " Science, vol. 312, no. 5774, pp. 734-737, 2006.
116. P. C. Kienesberger, T. Pulinilkunnil, J. Nagendran et al., "Early structural and metabolic cardiac remodelling in response to inducible adipose triglyceride lipase ablation, " Cardiovascular Research, vol. 99, no. 3, pp. 442-451, 2013.
117. A. Cittadini, C. S. Mantzoros, T. G. Hampton et al., "Cardiovascular abnormalities in transgenic mice with reduced brown fat: an animal model of human obesity, " Circulation, vol. 100, no. 21, pp. 2177-2183, 1999.
118. J. G. Duncan, J. L. Fong, D. M. Medeiros, B. N. Finck, and D. P. Kelly, "Insulin-resistant heart exhibits a mitochondrial biogenic response driven by the peroxisome proliferator-activated receptor-/PGC-1 gene regulatory pathway, " Circulation, vol. 115, no. 7, pp. 909-917, 2007.
119. J. Y. Cho and J. Park, "Contribution of natural inhibitors to the understanding of the PI3K/PDK1/PKB pathway in the insulinmediated intracellular signaling cascade, " International Journal of Molecular Sciences, vol. 9, no. 11, pp. 2217-2230, 2008.
120. S. A. Marsh, L. J. Dell'Italia, and J. C. Chatham, "Interaction of diet and diabetes on cardiovascular function in rats, " American Journal of Physiology-Heart and Circulatory Physiology, vol. 296, no. 2, pp. H282-H292, 2009.
121. J. Fuentes-Antrás, B. Picatoste, E. Ramrez, J. Egido, J. Tunón, and O. Lorenzo, "Targeting metabolic disturbance in the diabetic heart, " Cardiovascular Diabetology, vol. 14, article 17, 2015.
122. T. Mazzone, "Intensive glucose lowering and cardiovascular disease prevention in diabetes: reconciling the recent clinical trial data, " Circulation, vol. 122, no. 21, pp. 2201-2211, 2010.
123. S. Islas-Andrade, M. C. R. Monsalve, J. E. De La Pena, A. C. Polanco, M. A. Palomino, andA. F. Velasco, "Streptozotocinand alloxan in experimental diabetes: comparison of the twomodels in rats, "ActaHistochemica et Cytochemica, vol. 33, no. 3, pp. 201-208, 2000.
124. G. D. Lopaschuk and H. Tsang, "Metabolism of palmitate in isolated working hearts from spontaneously diabetic 'BB' Wistar rats, " Circulation Research, vol. 61, no. 6, pp. 853-858, 1987.
125. J. Buchanan, P. K. Mazumder, P. Hu et al., "Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity, " Endocrinology, vol. 146, no. 12, pp. 5341-5349, 2005.
126. F. Forcheron, A. Basset, P. Abdallah, P. D. Carmine, N. Gadot, andM. Beylot, "Diabetic cardiomyopathy: effects of fenofibrate andmetformin in an experimental model-the Zucker diabetic rat, " Cardiovascular Diabetology, vol. 8, article 16, 2009.
127. H. Iwatsuka, A. Shino, and Z. Suzuoki, "General survey of diabetic features of yellow KK mice, " Endocrinologia Japonica, vol. 17, no. 1, pp. 23-35, 1970.
128. K. Kawano, T. Hirashima, S. Mori, Y. Saitoh, M. Kurosumi, and T. Natori, "Spontaneous long-term hyperglycemic rat with diabetic complications: Otsuka Long-Evans Tokushima Fatty (OLETF) strain, " Diabetes, vol. 41, no. 11, pp. 1422-1428, 1992.
129. C. Tourrel, D. Bailbe, M. Lacorne, M.-J. Meile, M. Kergoat, and B. Portha, "Persistent improvement of type 2 diabetes in the Goto-Kakizaki ratmodel by expansion of the-cellmass during the prediabetic period with glucagon-like peptide-1 or exendin-4, " Diabetes, vol. 51, no. 5, pp. 1443-1452, 2002.
130. M. S. Winzell and B. Ahrén, "The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes, " Diabetes, vol. 53, supplement 3, pp. S215-S219, 2004.
131. H. Bar On, P. S. Roheim, and H. A. Eder, "Serum lipoproteins and apolipoproteins in rats with streptozotocin induced diabetes, " Journal of Clinical Investigation, vol. 57, no. 3, pp. 714-721, 1976.
132. J. Altomonte, L. Cong, S. Harbaran et al., "Foxo1 mediates insulin action on apoC-III and triglyceride metabolism, " The Journal of Clinical Investigation, vol. 114, no. 10, pp. 1493-1503, 2004.
133. C. Tang, J. E. Kanter, K. E. Bornfeldt, R. C. Leboeuf, and J. F. Oram, "Diabetes reduces the cholesterol exporter ABCA1 in mousemacrophages and kidneys, " Journal of Lipid Research, vol. 51, no. 7, pp. 1719-1728, 2010.
134. P. Naveilhan, L. Svensson, S. Nyström, A. J. Ekstrand, andP. Ernfors, "Attenuation of hypercholesterolemia and hyperglycemia in ob/ob mice by NPY Y2 receptor ablation, " Peptides, vol. 23, no. 6, pp. 1087-1091, 2002.
135. K. Kobayashi, T. M. Forte, S. Taniguchi, B. Y. Ishida, K. Oka, and L. Chan, "The db/db mouse, a model for diabetic dyslipidemia: Molecular characterization and effects of western diet feeding, " Metabolism: Clinical and Experimental, vol. 49, no. 1, pp. 22-31, 2000.
136. J. D. Sparks, T. L. Phung, M. Bolognino et al., "Lipoprotein alterations in 10-and 20-week-old Zucker diabetic fatty rats: hyperinsulinemic versus insulinopenic hyperglycemia, " Metabolism: Clinical and Experimental, vol. 47, no. 11, pp. 1315-1324, 1998.
137. T. Shimizugawa, M. Ono, M. Shimamura et al., "ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase, " The Journal of Biological Chemistry, vol. 277, no. 37, pp. 33742-33748, 2002.
138. S. D. Calligaris, M. Lecanda, F. Solis et al., "Mice longterm high-fat diet feeding recapitulates human cardiovascular alterations: an animalmodel to study the early phases of diabetic cardiomyopathy, " PLoS ONE, vol. 8, no. 4, Article ID e60931, 2013.
139. S. A. Oliveira-Junior, P. F. Martinez, D. M. Guizoni et al., "AT1 receptor blockade attenuates insulin resistance and myocardial remodeling in rats with diet-induced obesity, " PLoS ONE, vol. 9, no. 1, Article IDe86447, 2014.
140. I. I. Joffe, K. E. Travers, C. L. Perreault-Micale et al., "Abnormal cardiac function in the streptozotocin-induced, non-insulindependent diabetic rat: noninvasive assessment with Doppler echocardiography and contribution of the nitric oxide pathway, " Journal of the American College of Cardiology, vol. 34, no. 7, pp. 2111-2119, 1999.
141. F. S. Fein, B. Miller-Green, and E. H. Sonnenblick, "Altered myocardial mechanics in diabetic rabbits, " American Journal of Physiology-Heart and Circulatory Physiology, vol. 248, no. 5, part 2, pp. H729-H736, 1985.
142. L. M. Semeniuk, A. J. Kryski, and D. L. Severson, "Echocardiographic assessment of cardiac function in diabetic db/db and transgenic db/db-hGLUT4 mice, " American Journal of Physiology: Heart and Circulatory Physiology, vol. 283, no. 3, pp. H976-H982, 2002.
143. B. Rodrigues and J. H. McNeill, "Cardiac dysfunctioninisolated perfused hearts from spontaneously diabetic BB rats, " Canadian Journal of Physiology and Pharmacology, vol. 68, no. 4, pp. 514-518, 1990.
144. T. Pulinilkunnil, P. C. Kienesberger, J. Nagendran, N. Sharma, M. E. Young, and J. R. B. Dyck, "Cardiac-specific adipose triglyceride lipase overexpression protects from cardiac steatosis and dilated cardiomyopathy following diet-induced obesity, " International Journal of Obesity, vol. 38, no. 2, pp. 205-215, 2014.
145. Z. Lu, Y.-P. Jiang, X.-H. Xu, L. M. Ballou, I. S. Cohen, and R. Z. Lin, "Decreased L-type Ca2+ current in cardiac myocytes of type 1 diabetic akita mice due to reduced phosphatidylinositol 3-kinase signaling, " Diabetes, vol. 56, no. 11, pp. 2780-2789, 2007.
146. P. Pacher, L. Liaudet, F. G. Soriano, J. G. Mabley, E. Szabó, and C. Szabó, "The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes, " Diabetes, vol. 51, no. 2, pp. 514-521, 2002.
147. T. L. Broderick and A. K. Hutchison, "Cardiac dysfunction in the euglycemic diabetic-prone BB Wor rat, " Metabolism: Clinical and Experimental, vol. 53, no. 11, pp. 1391-1394, 2004.
148. A. Van den Bergh, W. Flameng, and P. Herijgers, "Type II diabetic mice exhibit contractile dysfunction but maintain cardiac output by favourable loading conditions, " European Journal of Heart Failure, vol. 8, no. 8, pp. 777-783, 2006.
149. Y.-C. Hsiao, K.-I. Suzuki, H. Abe, and T. Toyota, "Ultrastructural alterations in cardiac muscle of diabetic BB Wistar rats, " Virchows Archiv A, vol. 411, no. 1, pp. 45-52, 1987.
150. L. Li, Y. Hua, M. Dong et al., "Short-term lenalidomide (Revlimid) administration ameliorates cardiomyocyte contractile dysfunction in ob/ob obese mice, " Obesity, vol. 20, no. 11, pp. 2174-2185, 2012.
151. K. Saito, S. Nishi, T. Kashima, and H. Tanaka, "Histologic and ultrastructural studies on the myocardium in spontaneously diabetic KK mice: a new animal model of cardiomyopathy, " The American Journal of Cardiology, vol. 53, no. 2, pp. 320-323, 1984.
152. S. Boudina, S. Sena, H. Theobald et al., "Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins, " Diabetes, vol. 56, no. 10, pp. 2457-2466, 2007.
153. V. Akhileshwar, S. P. Patel, and S. S. Katyare, "Diabetic cardiomyopathy and reactive oxygen species (ROS) related parameters in male and female rats: a comparative study, " Indian Journal of Clinical Biochemistry, vol. 22, no. 1, pp. 84-90, 2007.